External Trial Stimulator 2 (Ets 2) Maintenance - Boston Scientific Vercise Gevia Instrucciones De Uso

• During an MRI examination, there are potential interactions with the implanted DBS
lead, Extension, and Stimulator, and risk of patient harm. Make sure to follow the
ImageReady™ MRI Guidelines for Boston Scientific DBS Systems, available on the
website www.bostonscientific.com/manuals.
• Psychiatric disturbances such as anxiety, depression, apathy, mania, insomnia, suicide,
or suicidal ideation or attempts
• Neuroleptic malignant syndrome or acute akinesia can occur very rarely
• Overstimulation or undesirable sensations, such as paresthesia, transient or persistent
• Pain, headache or discomfort, transient or persistent, including symptoms due to
neurostimulation
• Poor initial lead location
• Radiation exposure due to imaging (CT, fluoroscopy x-ray)
• Seizures
• Sensory changes
• Seroma, edema or hematoma
• Skin irritation or burns at neurostimulator site
• Speech or swallowing problems such as dysphasia, dysarthria or dysphagia, as well as
complications of dysphagia such as aspiration pneumonia
• Systemic symptoms-autonomic (tachycardia, sweating, fever, dizziness), changes in
renal function, urinary retention, sexual effects, gastrointestinal (nausea, bowel retention,
bloating)
• Thrombosis
• Visual disturbances or periorbital symptoms, such as diplopia, eyelid movement difficulty,
oculomotor difficulties or other visual field effects
• Weight changes

External Trial Stimulator 2 (ETS 2) Maintenance

The ETS 2 is used to conduct intraoperative stimulation testing during the lead implantation
procedure. Refer to the DFU listed on your DBS Reference Guide for detailed procedure and
guidelines for intraoperative testing.
External Trial Stimulator 2 (ETS 2) Maintenance
1.
2.
3.
4.
5.
Figure 1: External Trial Stimulator 2
Vercise Gevia™ Information for Prescribers
AB Connector
CD Connector
Stim Indicator Light
Stimulation ON/OFF
Battery Indicator Light
91168753-02 Rev A 9 of 505